| 2025-05-01 | +15.2% | earnings | Seeking Alpha | CONMED Corporation 2025 Q1 - Results - Earnings Call Presentation |
| 2025-05-01 | +15.2% | earnings | Seeking Alpha | Conmed projects full-year revenue growth of 4%-6% with improved supply chain outlook |
| 2025-05-01 | +15.2% | earnings | Seeking Alpha | CONMED Corporation (CNMD) Q1 2025 Earnings Call Transcript |
| 2024-04-24 | -12.8% | legal | SEC EDGAR | CNMD 8-K: 5.02 and (SEC Filing) |
| 2024-04-24 | -12.8% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2022-05-05 | -12.0% | legal | SEC EDGAR | CNMD 8-K: 1.01 and (SEC Filing) |
| 2024-01-31 | -11.3% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2025-04-30 | +11.0% | earnings | Seeking Alpha | CONMED Non-GAAP EPS of $0.95 beats by $0.14, revenue of $321.26M beats by $7.88M |
| 2025-04-30 | +11.0% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2025-12-04 | -9.9% | news | Finviz | Here's Why You Should Add CONMED Stock to Your Portfolio Now - Finviz |
| 2023-04-26 | +9.7% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2025-02-06 | -9.7% | earnings | Seeking Alpha | Conmed cut to Neutral at J.P. Morgan after guidance miss |
| 2025-02-06 | -9.7% | earnings | Seeking Alpha | Conmed anticipates $1.344B–$1.372B revenue in 2025 with focus on operational improvements |
| 2025-02-06 | -9.7% | earnings | Seeking Alpha | CONMED Corporation (CNMD) Q4 2024 Earnings Call Transcript |
| 2025-02-05 | -8.3% | earnings | Seeking Alpha | CONMED Non-GAAP EPS of $1.34 beats by $0.14, revenue of $345.9M beats by $4.85M |
| 2025-02-05 | -8.3% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2025-12-05 | -8.2% | news | Yahoo Finance | Why CONMED (CNMD) Shares Are Plunging Today - Yahoo Finance |
| 2025-12-05 | -8.2% | earnings | Stock Titan | CONMED (NYSE: CNMD) to leave gastroenterology, speed Gore VIABIL exit and flag 2026 EPS dilution - Stock Titan |
| 2025-12-05 | -8.2% | news | Benzinga | Why Is Conmed Stock Falling Friday? - Conmed (NYSE:CNMD) - Benzinga |
| 2022-05-04 | -7.9% | legal | SEC EDGAR | CNMD 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-10-30 | +7.8% | legal | SEC EDGAR | CNMD 8-K: 2.02, 5.02 (SEC Filing) |
| 2026-03-27 | -6.6% | news | StockStory | CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know |
| 2022-07-27 | -6.4% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2025-07-31 | +6.3% | news | Seeking Alpha | Conmed projects $20M annual supply chain savings as growth drivers accelerate |
| 2025-07-31 | +6.3% | earnings | Seeking Alpha | CONMED Corporation (CNMD) Q2 2025 Earnings Call Transcript |
| 2024-07-31 | -6.2% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2026-01-05 | +6.1% | news | Stock Titan | CONMED leaders to share company update at J.P. Morgan Healthcare Conference - Stock Titan |
| 2026-01-26 | -5.8% | earnings | Finviz | CONMED Earnings: What To Look For From CNMD - Finviz |
| 2022-01-26 | +5.6% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2026-01-28 | -5.5% | earnings | Seeking Alpha | CONMED Corporation 2025 Q4 - Results - Earnings Call Presentation |
| 2026-01-28 | -5.5% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2026-01-28 | -5.5% | earnings | Finviz | CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars - Finviz |
| 2026-01-28 | -5.5% | news | Business Wire | CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results - Business Wire |
| 2026-01-28 | -5.5% | earnings | Seeking Alpha | CONMED Corporation 2025 Q4 - Results - Earnings Call Presentation (NYSE:CNMD) 2026-01-28 - Seeking Alpha |
| 2025-06-12 | -5.2% | analyst | Seeking Alpha | Conmed falls as Needham downgrades to hold |
| 2022-06-13 | -5.0% | legal | SEC EDGAR | CNMD 8-K: 2.01, 7.01 (SEC Filing) |
| 2025-09-12 | -4.7% | news | simplywall.st | CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20 - simplywall.st |
| 2025-05-21 | -4.7% | news | Seeking Alpha | CONMED declares $0.20 dividend |
| 2025-05-21 | -4.7% | legal | SEC EDGAR | CNMD 8-K: 5.02, 5.07, 8.01 (SEC Filing) |
| 2025-05-21 | -4.7% | legal | Stock Titan | CONMED Sets $0.20 Dividend Payout: Key Dates for Shareholders to Secure Next Payment - Stock Titan |
| 2026-04-02 | -4.6% | news | Business Wire | CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026 |
| 2026-04-02 | -4.6% | earnings | Stock Titan | CONMED schedules April 29 earnings release, 4:30 p.m. call - Stock Titan |
| 2026-04-02 | -4.6% | legal | Stock Titan | CNMD SEC Filings - Conmed Corp 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-04-02 | -4.6% | executive | Stock Titan | CONMED (CNMD) CEO Pat Beyer awarded $1M in RSUs vesting over 3 years - Stock Titan |
| 2021-04-28 | +4.2% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2022-12-07 | +4.1% | legal | SEC EDGAR | CNMD 8-K: 5.02 and (SEC Filing) |
| 2025-10-24 | -3.9% | news | Kalkine Media | CONMED Corporation (NYSE:CNMD) NYSE Composite Surgical Edge - Kalkine Media |
| 2024-10-04 | -3.8% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2026-04-17 | +3.7% | earnings | MarketBeat | CONMED Corporation (NYSE:CNMD) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat |
| 2026-01-13 | -3.6% | news | Seeking Alpha | CONMED Corporation (CNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2026-01-13 | -3.6% | news | Seeking Alpha | CONMED Corporation (CNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-01-13 | -3.6% | news | Quiver Quantitative | $CNMD stock is down 9% today. Here's what we see in our data. - Quiver Quantitative |
| 2025-12-15 | -3.6% | news | Seeking Alpha | Conmed Taking On More Pain In The Pursuit Of Future Gain |
| 2026-04-21 | -3.4% | news | GlobeNewswire | [Latest] Global Surgical Drill Bits Market Size/Share Worth USD 540 Million by 2035 at a 5.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) |
| 2026-03-26 | -3.3% | news | StockStory | 3 Value Stocks with Open Questions |
| 2026-03-26 | -3.3% | news | Stock Titan | [SCHEDULE 13G/A] CONMED Corp Amended Passive Investment Disclosure - Stock Titan |
| 2026-04-10 | +3.2% | earnings | StockStory | Q4 Earnings Highs And Lows: CONMED (NYSE:CNMD) Vs The Rest Of The Surgical Equipment & Consumables - Diversified Stocks |
| 2024-08-09 | -3.1% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2024-03-27 | +3.1% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-07-18 | -3.0% | news | TradingView | Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know - TradingView |
| 2023-02-02 | +3.0% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2026-04-22 | -2.8% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | CNMD (CONMED Corporation) Q4 2025 EPS tops analyst estimates, sending shares up more than three percent today. - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-07-07 | -2.7% | legal | SEC EDGAR | CNMD 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-07-07 | -2.7% | news | GuruFocus | Conmed Corp (CNMD) Stock Price Down 3.29% on Jul 7 - GuruFocus |
| 2024-08-14 | -2.6% | legal | SEC EDGAR | CNMD 8-K: 5.02 and (SEC Filing) |
| 2025-11-05 | -2.6% | earnings | Seeking Alpha | CONMED Non-GAAP EPS of $1.08 beats by $0.03, revenue of $337.9M beats by $3.14M |
| 2025-11-05 | -2.6% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2025-11-05 | -2.6% | news | Business Wire | CONMED Corporation Announces Third Quarter 2025 Financial Results - Business Wire |
| 2025-06-16 | -2.5% | legal | SEC EDGAR | CNMD 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-05 | -2.5% | earnings | MarketBeat | Allspring Global Investments Holdings LLC Grows Stake in CONMED Corporation $CNMD - MarketBeat |
| 2026-04-04 | -2.5% | earnings | Simply Wall St. | Could CONMED’s Q4 Beat and Q1 Preview Reframe Its Margin Narrative for CNMD Investors? |
| 2026-04-04 | -2.5% | news | Simply Wall St. | Is It Time To Revisit CONMED (CNMD) After A 37% One Year Share Price Slide? |
| 2025-09-09 | -2.4% | legal | SEC EDGAR | CNMD 8-K: 5.02 and (SEC Filing) |
| 2023-02-27 | +2.4% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2023-12-05 | -2.4% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2021-08-12 | -2.4% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2022-11-15 | -2.4% | legal | SEC EDGAR | CNMD 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-04-16 | -2.4% | news | GuruFocus | Conmed Corp (CNMD) Stock Down 3.9% -- Now Undervalued? GF Score: 79/100 - GuruFocus |
| 2023-10-25 | +2.4% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2024-12-10 | -2.3% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2025-08-08 | -2.3% | news | Seeking Alpha | CONMED declares $0.20 dividend |
| 2025-08-08 | -2.3% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2022-05-31 | -2.3% | legal | SEC EDGAR | CNMD 8-K: 8.01 and (SEC Filing) |
| 2024-06-21 | +2.2% | news | Seeking Alpha | AirSeal Concerns Have Let Too Much Air Out Of Conmed’s Valuation (NYSE:CNMD) - Seeking Alpha |
| 2025-07-30 | +2.2% | earnings | Seeking Alpha | CONMED Non-GAAP EPS of $1.15 beats by $0.03, revenue of $342.3M beats by $3.88M |
| 2025-07-30 | +2.2% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2022-10-26 | -2.0% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2021-11-29 | -1.9% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2022-06-07 | -1.9% | legal | SEC EDGAR | CNMD 8-K: 1.01, 2.03, 3.02, 8.01 (SEC Filing) |
| 2021-05-20 | -1.9% | legal | SEC EDGAR | CNMD 8-K: 5.07 and 8.01 (SEC Filing) |
| 2026-01-08 | -1.8% | executive | Seeking Alpha | CONMED announces departure of CFO Todd Garner |
| 2026-01-08 | -1.8% | legal | SEC EDGAR | CNMD 8-K: 5.02 and (SEC Filing) |
| 2026-04-19 | +1.7% | earnings | MarketBeat | Tributary Capital Management LLC Boosts Stock Position in CONMED Corporation $CNMD - MarketBeat |
| 2026-04-18 | +1.7% | news | Stock Traders Daily | How Conmed Corp. - Ordinary Shares (CNMD) Affects Rotational Strategy Timing - Stock Traders Daily |
| 2026-04-18 | +1.7% | news | Xã Vĩnh Công | CONMED (CNMD) Stock DCF Valuation (+3.09%) 2026-04-18 - Social Buzz - Xã Vĩnh Công |
| 2022-12-05 | -1.7% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2022-08-02 | +1.7% | legal | SEC EDGAR | CNMD 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2025-02-28 | -1.6% | executive | Seeking Alpha | Repeated Disappointments On Growth And Margins Leaves Conmed Even Deeper In The Doghouse |
| 2023-10-28 | +1.6% | news | Seeking Alpha | Conmed: New Threats Shouldn’t Overshadow A Solid Core Business (NYSE:CNMD) - Seeking Alpha |
| 2025-09-05 | -1.5% | legal | Seeking Alpha | Conmed Constrained By Execution, Tariffs, And Sector Sentiment |
| 2022-03-07 | -1.5% | legal | SEC EDGAR | CNMD 8-K: 5.02 and (SEC Filing) |
| 2026-03-25 | +1.5% | news | Zacks | Are Options Traders Betting on a Big Move in CONMED Stock? |
| 2026-03-25 | +1.5% | news | TradingView | Are Options Traders Betting on a Big Move in CONMED Stock? - TradingView |
| 2026-03-13 | +1.4% | legal | SEC EDGAR | CNMD 8-K: 5.02 (SEC Filing) |
| 2026-03-13 | +1.4% | executive | Stock Titan | CONMED (NYSE: CNMD) appoints Andrew Moller interim principal financial officer - Stock Titan |
| 2022-08-09 | -1.4% | legal | SEC EDGAR | CNMD 8-K: 2.01, 7.01 (SEC Filing) |
| 2024-05-22 | -1.3% | legal | SEC EDGAR | CNMD 8-K: 5.07 and 8.01 (SEC Filing) |
| 2023-05-24 | -1.3% | legal | SEC EDGAR | CNMD 8-K: 5.07 and 8.01 (SEC Filing) |
| 2026-04-06 | -1.2% | news | StockStory | 3 Small-Cap Stocks Walking a Fine Line |
| 2025-12-14 | -1.1% | news | Seeking Alpha | Conmed Taking On More Pain In The Pursuit Of Future Gain (NYSE:CNMD) - Seeking Alpha |
| 2021-10-27 | +1.0% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2022-05-26 | -0.9% | legal | SEC EDGAR | CNMD 8-K: 5.07 and 8.01 (SEC Filing) |
| 2025-12-31 | -0.9% | news | Finviz | Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Finviz |
| 2023-07-26 | -0.9% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2021-07-16 | +0.9% | legal | SEC EDGAR | CNMD 8-K: 1.01, 2.03 (SEC Filing) |
| 2021-07-28 | +0.9% | legal | SEC EDGAR | CNMD 8-K: 2.02 and (SEC Filing) |
| 2022-06-02 | -0.9% | legal | SEC EDGAR | CNMD 8-K: 8.01 and (SEC Filing) |
| 2026-03-22 | +0.9% | news | simplywall.st | Is It Time To Reassess CONMED (CNMD) After A 39% One Year Share Price Slide - simplywall.st |
| 2024-05-28 | +0.9% | legal | SEC EDGAR | CNMD 8-K: 5.02 (SEC Filing) |
| 2025-04-01 | -0.9% | legal | SEC EDGAR | CNMD 8-K: 5.02 (SEC Filing) |
| 2025-04-24 | -0.8% | news | Stock Titan | CNMD Stock Price, News & Analysis - Stock Titan |
| 2022-02-28 | -0.8% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2025-02-18 | -0.7% | legal | TradingView | CONMED Corp SEC 10-K Report - TradingView |
| 2026-03-17 | -0.7% | news | Seeking Alpha | CONMED cut to Neutral at Piper Sandler on lack of catalysts |
| 2026-03-17 | -0.7% | news | Seeking Alpha | CONMED stock cut to Neutral at Piper Sandler (CNMD:NYSE) - Seeking Alpha |
| 2024-02-27 | -0.7% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2022-08-11 | +0.6% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2025-02-25 | -0.4% | news | Seeking Alpha | CONMED declares $0.20 dividend |
| 2025-02-25 | -0.4% | legal | SEC EDGAR | CNMD 8-K: 5.02, 8.01 (SEC Filing) |
| 2024-09-20 | +0.4% | legal | SEC EDGAR | CNMD 8-K: 5.02 (SEC Filing) |
| 2026-01-29 | -0.3% | earnings | Seeking Alpha | Conmed outlines 2026 revenue target of $1.345B–$1.375B while advancing portfolio focus and supply chain improvements |
| 2026-01-29 | -0.3% | earnings | Seeking Alpha | CONMED Corporation (CNMD) Q4 2025 Earnings Call Transcript |
| 2026-01-29 | -0.3% | earnings | Zacks Investment Research | CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up - Zacks Investment Research |
| 2025-04-28 | +0.2% | analyst | Seeking Alpha | CONMED downgraded at Stifel on Airseal disposable purchasing data, tariffs |
| 2026-03-18 | +0.2% | news | Stock Titan | CONMED (NYSE: CNMD) EVP granted 17,198 RSUs after award correction - Stock Titan |
| 2026-03-18 | +0.2% | news | Stock Titan | Executive VP at CONMED (CNMD) awarded 16,926 RSUs in corrected Form 4/A - Stock Titan |
| 2022-12-27 | +0.1% | legal | SEC EDGAR | CNMD 8-K: 1.01, 2.03 (SEC Filing) |
| 2023-08-10 | +0.1% | legal | SEC EDGAR | CNMD 8-K: 8.01 (SEC Filing) |
| 2026-04-09 | -0.1% | news | Zacks | Here's Why You Should Retain CONMED Stock in Your Portfolio Now |
| 2026-04-09 | -0.1% | earnings | MarketBeat | Tudor Investment Corp ET AL Boosts Stock Position in CONMED Corporation $CNMD - MarketBeat |
| 2025-11-06 | -0.1% | earnings | Seeking Alpha | Conmed signals $150M share repurchase program and narrows 2025 revenue guidance amid strategic portfolio focus |
| 2025-11-06 | -0.1% | earnings | Seeking Alpha | CONMED Corporation (CNMD) Q3 2025 Earnings Call Transcript |
| 2025-11-06 | -0.1% | earnings | Seeking Alpha | CONMED Corporation 2025 Q3 - Results - Earnings Call Presentation |